322 related articles for article (PubMed ID: 17577322)
1. Usefulness of mouse models to study the pathogenesis of Sjögren's syndrome.
Soyfoo MS; Steinfeld S; Delporte C
Oral Dis; 2007 Jul; 13(4):366-75. PubMed ID: 17577322
[TBL] [Abstract][Full Text] [Related]
2. Pathogenesis of Sjögren's syndrome: characteristics of different mouse models for autoimmune exocrinopathy.
van Blokland SC; Versnel MA
Clin Immunol; 2002 May; 103(2):111-24. PubMed ID: 12027416
[No Abstract] [Full Text] [Related]
3. Sjögren's syndrome: immunological response underlying the disease.
Brayer JB; Humphreys-Beher MG; Peck AB
Arch Immunol Ther Exp (Warsz); 2001; 49(5):353-60. PubMed ID: 11798133
[TBL] [Abstract][Full Text] [Related]
4. The possible etiopathogenic genes of Sjögren's syndrome.
Takei M; Shiraiwa H; Azuma T; Hayashi Y; Seki N; Sawada S
Autoimmun Rev; 2005 Sep; 4(7):479-84. PubMed ID: 16137615
[TBL] [Abstract][Full Text] [Related]
5. Genetic dissociation of dacryoadenitis and sialadenitis in a Sjogren's syndrome mouse model with common and different susceptibility gene loci.
Kamao T; Miyazaki T; Soga Y; Komori H; Terada M; Ohashi Y; Nose M
Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3257-65. PubMed ID: 19218603
[TBL] [Abstract][Full Text] [Related]
6. Lymphocytic infiltration and goblet cell marker alteration in the conjunctiva of the MRL/MpJ-Fas(lpr) mouse model of Sjögren's syndrome.
Diebold Y; Chen LL; Tepavcevic V; Ferdman D; Hodges RR; Dartt DA
Exp Eye Res; 2007 Mar; 84(3):500-12. PubMed ID: 17208228
[TBL] [Abstract][Full Text] [Related]
7. The role of caspase cascade on the development of primary Sjögren's syndrome.
Hayashi Y; Arakaki R; Ishimaru N
J Med Invest; 2003 Feb; 50(1-2):32-8. PubMed ID: 12630566
[TBL] [Abstract][Full Text] [Related]
8. A novel NOD-derived murine model of primary Sjögren's syndrome.
Robinson CP; Yamachika S; Bounous DI; Brayer J; Jonsson R; Holmdahl R; Peck AB; Humphreys-Beher MG
Arthritis Rheum; 1998 Jan; 41(1):150-6. PubMed ID: 9433880
[TBL] [Abstract][Full Text] [Related]
9. Two NOD Idd-associated intervals contribute synergistically to the development of autoimmune exocrinopathy (Sjögren's syndrome) on a healthy murine background.
Cha S; Nagashima H; Brown VB; Peck AB; Humphreys-Beher MG
Arthritis Rheum; 2002 May; 46(5):1390-8. PubMed ID: 12115247
[TBL] [Abstract][Full Text] [Related]
10. Sjögren's syndrome in the NOD mouse model is an interleukin-4 time-dependent, antibody isotype-specific autoimmune disease.
Gao J; Killedar S; Cornelius JG; Nguyen C; Cha S; Peck AB
J Autoimmun; 2006 Mar; 26(2):90-103. PubMed ID: 16413168
[TBL] [Abstract][Full Text] [Related]
11. Immunopathologic mechanisms of inflammatory vascular disease in primary Sjögren's syndrome--a model.
Alexander EL
Scand J Rheumatol Suppl; 1986; 61():280-5. PubMed ID: 3473645
[TBL] [Abstract][Full Text] [Related]
12. [Investigations of various animal models for Sjögren's syndrome].
Hayashi Y
Nihon Rinsho; 1995 Oct; 53(10):2383-8. PubMed ID: 8531342
[TBL] [Abstract][Full Text] [Related]
13. [Natural biological models of autoimmune diseases].
Pleskovskaia GN
Revmatologiia (Mosk); 1991; (4):38-44. PubMed ID: 1805332
[No Abstract] [Full Text] [Related]
14. Two different types of sialoadenitis in the NOD- and MRL/lpr mouse models for Sjögren's syndrome: a differential role for dendritic cells in the initiation of sialoadenitis?
van Blokland SC; van Helden-Meeuwsen CG; Wierenga-Wolf AF; Drexhage HA; Hooijkaas H; van de Merwe JP; Versnel MA
Lab Invest; 2000 Apr; 80(4):575-85. PubMed ID: 10780673
[TBL] [Abstract][Full Text] [Related]
15. [Progress in understanding the pathogenesis of Sjögren's syndrome in non-obese diabetic mice].
Su YC; Wu LL; Xiang RL
Sheng Li Ke Xue Jin Zhan; 2012 Jun; 43(3):171-6. PubMed ID: 23019918
[TBL] [Abstract][Full Text] [Related]
16. Non-depleting anti-CD4 antibody not only prevents onset but resolves sialadenitis in NOD mice.
Thompson C; Jacobsen H; Pomeranz Krummel D; Nagai K; Cooke A
Autoimmunity; 2004 Dec; 37(8):549-54. PubMed ID: 15763917
[TBL] [Abstract][Full Text] [Related]
17. Sjögren's syndrome-like disease of C57BL/6.NOD-Aec1 Aec2 mice: gender differences in keratoconjunctivitis sicca defined by a cross-over in the chromosome 3 Aec1 locus.
Nguyen C; Singson E; Kim JY; Cornelius JG; Attia R; Doyle ME; Bulosan M; Cha S; Peck AB
Scand J Immunol; 2006 Sep; 64(3):295-307. PubMed ID: 16918699
[TBL] [Abstract][Full Text] [Related]
18. Impact of gender on exocrine gland inflammation in mouse models of Sjögren's syndrome.
Toda I; Sullivan BD; Rocha EM; Da Silveira LA; Wickham LA; Sullivan DA
Exp Eye Res; 1999 Oct; 69(4):355-66. PubMed ID: 10504269
[TBL] [Abstract][Full Text] [Related]
19. Sjögren's syndrome: a review of aetiology, pathogenesis, diagnosis and management.
Bayetto K; Logan RM
Aust Dent J; 2010 Jun; 55 Suppl 1():39-47. PubMed ID: 20553243
[TBL] [Abstract][Full Text] [Related]
20. The enigmatic role of interleukin-12 in the pathogenesis of Sjögren's syndrome: comment on the article by Vosters et al.
Airoldi I; Di Carlo E; Pistoia V
Arthritis Rheum; 2010 Jul; 62(7):2180; author reply 2180-1. PubMed ID: 20506334
[No Abstract] [Full Text] [Related]
[Next] [New Search]
